Clinical Trials Logo

Filter by:
NCT ID: NCT02382705 Completed - Capsule Endoscopy Clinical Trials

SB3 Battery Life Observational Study

Start date: February 2015
Phase:
Study type: Observational

Capsule endoscopy (CE) is a non-invasive means of visualizing the small bowel. Common indications for CE include obscure gastrointestinal (GI) bleeding, inflammatory bowel disease like crohn's disease or ulcerative colitis, celiac disease, and polyposis syndrome. While CE has high diagnostic value for small bowel lesions, a significant limitation of this technology is the finite battery life which results in incomplete examination of the small bowel approximately 16.5% of the time. Numerous attempts of using pharmacological (e.g. prokinetics, purgatives) as well as non-pharmacological measures (e.g. real-time viewer, chewing gum) to improve completion rates, defined by entry of CE into the cecum, led to mixed results. Currently routine use of prokinetics (agents that speeds up gut motility) is not recommended. This study aims to determine whether longer battery of the newer generation capsule endoscopy system improves study completion rate and diagnostic yield.

NCT ID: NCT02382211 Completed - Clinical trials for Infection in Solid Organ Transplant Recipients

T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays

PROTECT
Start date: January 2015
Phase:
Study type: Observational

The T-SPOT assay quantifies the number of peripheral blood interferon-γ producing effector T cells [spot forming cells/million peripheral blood mononuclear cells - PBMC)]. The T-SPOT platform technology can be applied to diagnose and monitor any major disease process driven by a T cell response, including a viral disease such as cytomegalovirus (CMV) infection (the T-SPOT.CMV assay) or an allograft rejection (the T-SPOT.PRT assay).

NCT ID: NCT02381834 Completed - Clinical trials for Urinary Tract Infection

Evaluation of a Novel Midstream Urine Collection Technique for Infants in the Emergency Department

Start date: March 2015
Phase: N/A
Study type: Interventional

Urinalysis and urine culture are commonly employed laboratory tests in the Emergency Department (ED), particularly for the purposes of investigating febrile infants in whom bacterial etiologies must be ruled out. The standard of care for obtaining sterile urine specimens in this age group remains transurethral bladder catheterization, an invasive procedure that is painful and has the potential for causing specimen contamination and iatrogenic urinary tract infection (UTI). A recent study by Herreros Fernández et al (2013) described a novel bladder stimulation technique for newborns that facilitates midstream urine collection. The success rate for this procedure was 86.3%. It remains unknown however as to whether this technique is reproducible amongst infants who present to the ED with a potentially greater severity of illness. The primary objective of this study is to determine the success rate of this technique in children ≤ 90 days old in the ED.

NCT ID: NCT02381093 Completed - Clinical trials for Cardiopulmonary Resuscitation

Does Contextual Interference Improve Retention of Basic Life Support Skills? A Randomized Controlled Trial

Start date: July 2015
Phase: N/A
Study type: Interventional

The current method of teaching Basic Life Support (BLS) courses involves a practice schedule where learners rotate through each station once, without repetition. Laypeople learning within this blocked schedule may experience poor skill retention, resulting in suboptimal delivery of Cardiopulmonary Resuscitation (CPR). Implementing a Contextual Interference (CI) practice scheduling method to BLS training would involve presenting each station multiple times within the same timeframe. CI is known to lead to better retention in other domains, such as sport and engineering. Our project will test the effect of CI on the long-term retention of BLS skills. We hypothesize that participants trained in BLS using CI techniques will have superior skill retention at 3 months compared to those trained with the conventional BLS course.

NCT ID: NCT02381080 Completed - Clinical trials for B-Cell Chronic Lymphocytic Leukemia

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

Start date: May 19, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of a moderate Cytochrome P450 (CYP) 3A inhibitor (erythromycin) and a strong CYP3A inhibitor (voriconazole) on the steady-state pharmacokinetics (PK [the study of the way a drug enters and leaves the blood and tissues over time]) of repeated oral doses of ibrutinib in participants with B-cell malignancy (cancer or other progressively enlarging and spreading tumors).

NCT ID: NCT02380352 Completed - Clinical trials for Community-acquired Pneumonia

Short-course Antimicrobial Therapy for Paediatric Respiratory Infections

SAFER
Start date: September 2016
Phase: Phase 4
Study type: Interventional

Randomized controlled double-blind non-inferiority clinical trial to determine whether five days of high-dose amoxicillin leads to comparable rates of early clinical cure compared with 10 days of high-dose amoxicillin for previously healthy children with mild community-acquired pneumonia.

NCT ID: NCT02379832 Completed - Preterm Birth Clinical Trials

Pre-Eclampsia And Growth Restriction: a Longitudinal Study

PEARL
Start date: March 2015
Phase:
Study type: Observational [Patient Registry]

Preeclampsia may have several causes leading to different characteristics of the pathology. Differentiation between the "type of preeclampsia" would help to treat patients more accurately. This project aims to identify early markers that are specific to each type of preeclampsia (early or late, with or without growth restriction). Through a case-control study, many data will be collected prospectively (serum markers, ultrasonographic markers, maternal factors) among nulliparous women with no sign of preeclampsia (as soon as the first trimester) and nulliparous women with preeclampsia (at diagnosis).

NCT ID: NCT02379637 Completed - Clinical trials for Common Cold Associated With Cough

Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough

NAC cold cough
Start date: January 2015
Phase: Phase 2
Study type: Interventional

This study is designed to improve knowledge regarding the initial effectiveness of N-acetylcysteine (NAC) on cold and cough symptoms.

NCT ID: NCT02378766 Completed - HIV Clinical Trials

Evaluation of Web-based Interventions to Support People Living With HIV in the Adoption of Health Behaviors

LHIVEHEALTHY
Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a web-based tailored intervention to support persons living with HIV (PLHIV) manage the demands inherent to their health condition, particularly as regards to the adoption of health behaviours such as being physically active, following a healthy diet and quitting smoking. This randomized controlled trial is currently conducted entirely online at www.lhivehealthy.ca

NCT ID: NCT02378467 Completed - Cystic Fibrosis Clinical Trials

Saline Hypertonic in Preschoolers

SHIP
Start date: March 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks improves the lung clearance index by multiple breath nitrogen washout in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 5) with cystic fibrosis.